New AI model offers hope for detecting brain cancer spread without surgery Researchers Have Developed A…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery.

Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s

March 8, 2024

Fate Therapeutics announces Bob Valamehr as president and CEO

Fate Therapeutics’ current president of research and development, Bob Valamehr, will take over as president and CEO effective from 1 January 2025. Credit: Piotr Swat/Shutterstock.

December 2, 2024

Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed – Biotech Investments

Pentixapharm Holding AG / Key word(s): IPO Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed 01-Oct-2024

October 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.